Omniox Stock

omniox.comBioTechFounded: 2006Funding to Date: $87.65MM

Omniox is a provider of biotherapeutics for ischemic, hypoxic, and anemic diseases in oncology, cardiovascular and stroke diseases, diabetes, trauma, surgery, and sickle cell crises with a focused on overcoming biochemical shortcomings in prior efforts at oxygen and nitric oxide delivery.

Register for Details

For more details on financing and valuation for Omniox, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Stephen Cary Ph.D
Co-Founder, Chief Executive Officer & Board Member
Jonathan Winger Ph.D
Founder & Vice President, Process Development and New Product Introduction
Michael Marletta Ph.D
Co-Founder & Chairman

Board Members

Ajit Shah Ph.D
Jeffrey Samberg
Acadia Woods Partners
John Wesley
Michael Marletta Ph.D

Other companies like Omniox in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM